Virtual Patient Groups for Sarcoidosis Associated Fatigue
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Cleveland Clinic
About this trial
This research study is testing whether Mindfulness-Based Stress Reduction (MBSR) can help reduce fatigue in people with sarcoidosis. The study will also look at whether MBSR can improve symptoms of anxiety and depression.
Participants will be placed into one of two groups:
* One group will take part in an 8-week virtual MBSR program, attend weekly online sessions, keep a daily mindfulness journal, and complete surveys about fatigue, anxiety, and depression. * The other group will join a virtual support group once a month for 5 months and complete the same surveys.
The goal is to see which approach is more helpful for improving fatigue and mental well-being in people with sarcoidosis.
Eligibility criteria
Qualifiers
Self reported diagnosis of sarcoidosis
Fatigue defined as FAS score ≥ 22
Age ≥ 18 years old
Ability to speak and read English
Disqualifiers
Current daily meditation practice
Prior history of engaging in formal mindfulness-based interventions including: MBSR, MBCT, Acceptance and Commitment therapy, Dialectical Behavior Therapy
Any condition that would prevent being a suitable candidate for the group intervention (as determined by screening interview) including suicidal ideation.
Lack of access to any form of online video access
Trial design
Treatments tested in this trial
- Virtual Mindfulness Based Stress Reduction Group
- Virtual sarcoidosis support group
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
The Cleveland Clinic
Lead sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
National Center for Advancing Translational Sciences (NCATS)
Collaborator
Source ClinicalTrials.gov